Guardian Pharmacy Services announced a proposed underwritten public offering of 5 million shares of Class A common stock. The offering includes 3.98 million shares sold by certain selling stockholders and 1.02 million newly issued shares sold by the company as part of a non-dilutive synthetic secondary transaction. Guardian said it plans to use all net proceeds it receives to repurchase from certain stockholders a number of shares equal to the 1.02 million newly issued shares, at the public offering price less the underwriting discount. Selling stockholders plan to grant underwriters a 30-day option to buy up to an additional 0.75 million shares. BofA Securities, Jefferies and Raymond James are acting as joint bookrunners, with Stephens and Oppenheimer as co-managers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardian Pharmacy Services Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260318490101) on March 18, 2026, and is solely responsible for the information contained therein.